Review article: the clinical role of anti-TNFalpha antibody treatment in Crohn's disease. - Wikidata - wikimedia - TriplyDB

Review article: the clinical role of anti-TNFalpha antibody treatment in Crohn's disease.

Review article: the clinical role of anti-TNFalpha antibody treatment in Crohn's disease.

http://www.wikidata.org/entity/Q33904308

about

Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease Economic implications of biological therapy for Crohn's disease Infliximab.Psoriasis: the future.Infliximab therapy in pediatric Crohn's disease: a review.On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha-neutralizing antibody: a possible healthcare-associated case?Infliximab treatment of rheumatoid arthritis and Crohn's disease.Morphological characterisation of Crohn's disease fistulae Controlled-release and local delivery of therapeutic antibodies.Engineering and characterization of a mouse/human chimeric anti-phencyclidine monoclonal antibody.Economic burden of inflammatory bowel disease: a UK perspective.Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies.Construction, affinity maturation, and biological characterization of an anti-tumor-associated glycoprotein-72 humanized antibody.Pulmonary actinomycosis complicating infliximab therapy for Crohn disease.Pulmonary actinomycosis complicating infliximab therapy for Crohn's disease.TNF-alpha hyperpolarizes membrane potential and potentiates the response to nicotinic receptor stimulation in cultured rat myenteric neurones.Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn's disease.The effect of spironolactone on experimental periodontitis in rats.Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients.Profile of infliximab in the treatment of pediatric Crohn's disease.Depletion of immunoglobulin M memory B cells is associated with splenic hypofunction in inflammatory bowel disease.Catalytic digestion of human tumor necrosis factor-α by antibody heavy chain.Effects of anti-tumour necrosis factor-alpha therapy on the quality of life in Crohn's disease.

P2860

Q24247745-02714F13-9E0B-4380-B211-06442760D87F Q24669999-F48447B9-1DB6-4C7F-9517-1188E423E2BC Q26772179-DACA12F6-3CB5-434F-BA72-7922AA80495A Q30307998-498E815F-3CB1-4733-B9FC-D56B2823A424 Q31001401-7DB8A928-5D94-4BD9-9001-DCC8B2D2E633 Q35026358-E4F14156-34BD-4815-A8B1-3ACFB6CF368A Q35059648-F9C85917-1060-45D8-A383-1B088C47EECB Q35187336-1396C8E7-8B79-470F-AA91-3F249DC769A6 Q35201036-1C7DBA12-9380-4C9D-BE89-D1FA2E838D6A Q35596840-3B413B0D-5DA0-43AB-93B2-460354186B81 Q35842644-A94087AC-4AFB-4A6A-8905-1ABD3E63FA64 Q36453638-77E74878-D816-4827-9241-429BEBAFC69D Q37763169-EE0835DA-F293-4B95-857D-BA535D86715F Q38072598-D5FE16F1-1672-4435-964A-60681F762A3F Q40331204-DA6B911A-201C-41D9-BDAE-20BC503913FF Q40400866-C2B4B9A9-F7A3-4756-95F6-3D68B0A90494 Q41819384-DE480676-9076-4741-A40E-454F418480DF Q42460246-0FCEA965-AC66-4218-BFFD-8B527E040E5F Q44898872-32969A98-F76F-46CC-87D5-A8B472845D51 Q46457429-0D5A8200-D335-46EE-9D4C-51E96A6360FB Q47686523-973C15EA-9492-4E9D-97D6-FCE8C6E3130A Q49165025-99B5FCE2-DD7D-433E-A79F-CD24EA14EEB1 Q50758825-4D7E3444-CBEA-418B-8A1B-49CD970C226E Q53305638-96BF3C14-D165-4830-91A5-B67D2B6EFFEF Q53433625-822D569D-92A6-430B-A4E3-1BDE1038BB6C

P2860

Review article: the clinical role of anti-TNFalpha antibody treatment in Crohn's disease.

http://www.wikidata.org/entity/Q33904308

description

2000 nî lūn-bûn

@nan

2000 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Review article: the clinical role of anti-TNFalpha antibody treatment in Crohn's disease.

@ast

Review article: the clinical role of anti-TNFalpha antibody treatment in Crohn's disease.

@en

type

label

Review article: the clinical role of anti-TNFalpha antibody treatment in Crohn's disease.

@ast

Review article: the clinical role of anti-TNFalpha antibody treatment in Crohn's disease.

@en

prefLabel

Review article: the clinical role of anti-TNFalpha antibody treatment in Crohn's disease.

@ast

Review article: the clinical role of anti-TNFalpha antibody treatment in Crohn's disease.

@en

P1433

Q33904308-10F7902B-5A86-463B-8F52-7B2FEB27ABCA

P1476

Q33904308-0B876142-3FDB-4537-874C-FE4DC29F4915

P2093

Q33904308-4541DB62-9FCA-4AF2-B597-3D3579DEF9CB

Q33904308-56812992-ADAA-463E-8A2E-0D820D2EE424

P2860

Q33904308-073505D3-665D-48F9-B996-77315F4A2277

Q33904308-07801DF1-E29A-4AA8-8551-CB1288B8DD21

Q33904308-0E139017-E4C5-4679-B0E2-041A5EF0A006

Q33904308-0FFA3F3B-0717-4F8E-A1F2-CEBCCA08D217

Q33904308-128992EE-8EC7-4023-871B-32214EAC3294

Q33904308-12A70D14-005F-42B7-9FD0-6F32638CE2E6

Q33904308-14CAC382-4ED7-4B1F-BECD-3DC9AA73CA87

Q33904308-19ECB751-2387-4771-9FD9-3A75E7631446

Q33904308-1DCE1BA4-2CF6-477D-926C-A27DE9FE50AA

Q33904308-29A740C9-FC8A-4FD1-819D-E24159E00053

P304

Q33904308-72BC2F70-CDC2-48AE-8289-964CB0A3C37D

P31

Q33904308-BB43EB71-E3A4-4D9D-A41E-8EFE52A3D671

P356

Q33904308-874385AF-B95D-49BE-9EEB-663E6349A579

P407

Q33904308-C0E22FBA-08F5-40DF-AEB1-F361333B73F0

P433

Q33904308-40453E86-8756-4B72-B7CD-CEF7C410ADF4

P478

Q33904308-4249F781-EE9E-4532-9545-EEE4724B592C

P577

Q33904308-AB104275-68CC-4CDC-8CBF-241A9BE7294C

P5875

Q33904308-B2CA3A22-E121-426E-B17A-F561F5047656

P698

Q33904308-EF4BEF6F-CD42-4C05-AFE0-54FF764C99E7

P921

Q33904308-A54D8B0D-6404-425E-A886-D947F7FEAC99

P356

J.1365-2036.2000.00777.X

P1433

Alimentary Pharmacology & Therapeutics

P1476

Review article: the clinical role of anti-TNFalpha antibody treatment in Crohn's disease.

@en

P2093

Bell SJ

http://www.w3.org/2001/XMLSchema#string

Kamm MA

http://www.w3.org/2001/XMLSchema#string

P2860

Reshaping human antibodies for therapy

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

The relationship between infliximab treatment and lymphoma in Crohn's disease.

Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.

Anti-TNF strategies in Crohn's disease: mechanisms, clinical effects, indications.

Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease

Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.

Infliximab for the treatment of fistulas in patients with Crohn's disease.

Cyclosporine in severe ulcerative colitis refractory to steroid therapy.

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody.

P304

501-514

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2036.2000.00777.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2000-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12525483

http://www.w3.org/2001/XMLSchema#string

P698

10792111

http://www.w3.org/2001/XMLSchema#string

P921

Crohn's disease